Cargando…
Inhibition of endolysosome fusion increases exosome secretion
Exosomes are small vesicles that are secreted from cells to dispose of undegraded materials and mediate intercellular communication. A major source of exosomes is intraluminal vesicles within multivesicular endosomes that undergo exocytic fusion with the plasma membrane. An alternative fate of multi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202829/ https://www.ncbi.nlm.nih.gov/pubmed/37213076 http://dx.doi.org/10.1083/jcb.202209084 |
_version_ | 1785145854020026368 |
---|---|
author | Shelke, Ganesh Vilas Williamson, Chad D. Jarnik, Michal Bonifacino, Juan S. |
author_facet | Shelke, Ganesh Vilas Williamson, Chad D. Jarnik, Michal Bonifacino, Juan S. |
author_sort | Shelke, Ganesh Vilas |
collection | PubMed |
description | Exosomes are small vesicles that are secreted from cells to dispose of undegraded materials and mediate intercellular communication. A major source of exosomes is intraluminal vesicles within multivesicular endosomes that undergo exocytic fusion with the plasma membrane. An alternative fate of multivesicular endosomes is fusion with lysosomes, resulting in degradation of the intraluminal vesicles. The factors that determine whether multivesicular endosomes fuse with the plasma membrane or with lysosomes are unknown. In this study, we show that impairment of endolysosomal fusion by disruption of a pathway involving the BLOC-one-related complex (BORC), the small GTPase ARL8, and the tethering factor HOPS increases exosome secretion by preventing the delivery of intraluminal vesicles to lysosomes. These findings demonstrate that endolysosomal fusion is a critical determinant of the amount of exosome secretion and suggest that suppression of the BORC–ARL8–HOPS pathway could be used to boost exosome yields in biotechnology applications. |
format | Online Article Text |
id | pubmed-10202829 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-102028292023-11-22 Inhibition of endolysosome fusion increases exosome secretion Shelke, Ganesh Vilas Williamson, Chad D. Jarnik, Michal Bonifacino, Juan S. J Cell Biol Article Exosomes are small vesicles that are secreted from cells to dispose of undegraded materials and mediate intercellular communication. A major source of exosomes is intraluminal vesicles within multivesicular endosomes that undergo exocytic fusion with the plasma membrane. An alternative fate of multivesicular endosomes is fusion with lysosomes, resulting in degradation of the intraluminal vesicles. The factors that determine whether multivesicular endosomes fuse with the plasma membrane or with lysosomes are unknown. In this study, we show that impairment of endolysosomal fusion by disruption of a pathway involving the BLOC-one-related complex (BORC), the small GTPase ARL8, and the tethering factor HOPS increases exosome secretion by preventing the delivery of intraluminal vesicles to lysosomes. These findings demonstrate that endolysosomal fusion is a critical determinant of the amount of exosome secretion and suggest that suppression of the BORC–ARL8–HOPS pathway could be used to boost exosome yields in biotechnology applications. Rockefeller University Press 2023-05-22 /pmc/articles/PMC10202829/ /pubmed/37213076 http://dx.doi.org/10.1083/jcb.202209084 Text en This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply. https://creativecommons.org/licenses/by-nc-sa/4.0/http://www.rupress.org/terms/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Shelke, Ganesh Vilas Williamson, Chad D. Jarnik, Michal Bonifacino, Juan S. Inhibition of endolysosome fusion increases exosome secretion |
title | Inhibition of endolysosome fusion increases exosome secretion |
title_full | Inhibition of endolysosome fusion increases exosome secretion |
title_fullStr | Inhibition of endolysosome fusion increases exosome secretion |
title_full_unstemmed | Inhibition of endolysosome fusion increases exosome secretion |
title_short | Inhibition of endolysosome fusion increases exosome secretion |
title_sort | inhibition of endolysosome fusion increases exosome secretion |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202829/ https://www.ncbi.nlm.nih.gov/pubmed/37213076 http://dx.doi.org/10.1083/jcb.202209084 |
work_keys_str_mv | AT shelkeganeshvilas inhibitionofendolysosomefusionincreasesexosomesecretion AT williamsonchadd inhibitionofendolysosomefusionincreasesexosomesecretion AT jarnikmichal inhibitionofendolysosomefusionincreasesexosomesecretion AT bonifacinojuans inhibitionofendolysosomefusionincreasesexosomesecretion |